General Counsel
General Counsel at Oruka Therapeutics, Inc., filing insider transactions between 2026-08-14 and 2026-09-21.
| SEC ↗ |
| 2026-09-21 | ORKA | Sale | 601 | $94.44 | $57K | SEC ↗ |
| 2026-09-15 | ORKA | Sale | 1,039 | $95.71 | $99K | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 10.2K | $109.11 | $1.1M | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 9,193 | $110.00 | $1.0M | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 10.4K | $107.14 | $1.1M | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 14.7K | $107.97 | $1.6M | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 3,630 | $106.05 | $385K | SEC ↗ |
| 2026-08-14 | ORKA | Sale | 3,847 | $111.14 | $428K | SEC ↗ |